Pharmaceutical Technology and Translation

Josbert (Bart) (PhD in Pharmaceutics, Utrecht University, 2004) started the company Enceladus Pharmaceuticals in 2004. With the help of grants, investments and non-equity funding, he managed to perform a series of preclinical and clinical trials focusing on three different liposomal nanomedicine products. Since 2012, he has worked as a part-time assistant professor at the University of Twente. In 2015, he also took up a group leader position at RWTH Aachen, to extend his work on the development of nanomedicines for the treatment of inflammatory disorders and cancer.
Dr. Josbert Metselaar

Group members

S. M. Ali Dadfar

Ali (M.SC. Chemical Engineering, Polymer Science and Nanotechnology, Sharif University of Technology, December 2009) works on temperature-responsive and multi-drug-loaded liposomes for tumor targeted combination therapy. In addition, he also participates in project on drug-loaded polymeric micelles for theranostic application.

A. Dadfar

Marek Weiler

Marek works as a technician in the Probe Design for Molecular Imaging group. He assists MSc and PhD students in the synthesis and characterization of (antibody-targeted) MB, PLGA-based nanoparticles USPIO and MR/PET-probes. He is also responsible for HPLC- and GC-based analyses. He operates many imaging devices and performs tasks for sharing and archiving of large amounts of image data

M. Weiler

Robert Tungadi

Robert (M.Sc. Pharmacy, Hasanuddin University, Indonesia, 2008) is working on liposome formulations for the delivery of natural compounds. His project, which primarily focuses on pharmaceutical engineering and on in vitro and in vivo testing, is funded via an Indonesian scholarship.

R. Tungadi